Sexually Transmitted Infection and Chlamydia/Gonorrhea Testing Have Not Returned to Pre-COVID Levels, 5 U.S. Jurisdictions, 2018-2022
We evaluated whether sexually transmitted infection clinic visits and chlamydia/gonorrhea tests in 5 jurisdictions had returned to pre-coronavirus disease levels by 2022. Patient volume and chlamydia/gonorrhea testing have not returned to pre-coronavirus disease levels, especially among people younger than 30 years.
Authors
- Anna B. Cope (ORCID: https://orcid.org/0000-0001-7599-196X)
- Mohammad Rahman
- River A. Pugsley (ORCID: https://orcid.org/0009-0007-0679-3688)
- Jill C. Diesel (ORCID: https://orcid.org/0000-0002-6407-7280)
- Nicole L. Davis (ORCID: https://orcid.org/0000-0002-0070-6826)
- Bryce Furness
- James B. Kent (ORCID: https://orcid.org/0009-0006-3364-9924)
- Gayoung Lee (ORCID: https://orcid.org/0000-0002-7133-4839)
- Ashleigh Dunworth
Institutions
- Centers for Disease Control and Prevention (US)
- Michigan Department of Health and Human Services (US)
- Virginia Department of Health (US)
- District of Columbia Department of Health (US)
- Schlumberger (Ireland) (IE)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- North Carolina Division of Public Health (US)
Publication Details
- Journal
- Sexually Transmitted Diseases
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1097/olq.0000000000002150
- Citations
- 1
- Primary Topic
- Genital Health and Disease
- Type
- article
- Field-Weighted Citation Impact
- 2.01